The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Whistleblower protection bill clears legislative floor
12/27/2024 10:38 PM - Society
Changhua Court backs plaintiff's compensation claim in scam case
12/27/2024 10:29 PM - Society
In a first, Taiwan, Belgium join hands in collecting evidence
12/27/2024 10:05 PM - Business
Taiwan's economy improves in November on AI demand, exports
12/27/2024 08:30 PM - Society
200,000 doses of Novavax JN. 1 COVID-19 vaccine available from Jan. 1
12/27/2024 08:09 PM